CoChat

Prevalence and characteristics of the metabolic syndrome in 2479 hypopituitary patients with adult-onset GH deficiency before GH replacement: a KIMS analysis

Verhelst, Johan, Mattsson, Anders F, Luger, Anton, Thunander, Maria, Góth, Miklós I, Kołtowska-Häggström, Maria, Abs, Roger · 2011 · European Journal of Endocrinology

The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.

Abstract

Objective: An increased risk of cardiovascular morbidity and mortality in adult GH deficiency (GHD) may be related to hypopituitarism but also to the presence of the metabolic syndrome (MetS). Our objective was to investigate the characteristics and prevalence of MetS as well as its comorbidities in adult GHD. Design: In KIMS (Pfizer International Metabolic Database) 2479 patients with severe adult-onset GHD, naïve to GH replacement, with complete information on all MetS components were found. MetS was defined according to the National Cholesterol Education Program's Adult Treatment Panel III (NCEP) and the International Diabetes Foundation (IDF). Methods: The prevalence of MetS was calculated and compared with previously published data from the normal population. Associations were assessed between background variables, baseline variables, comorbidities, and MetS. Results: MetS was present in 43.1% (NCEP) and in 49.1% (IDF) of patients, clearly higher than data from the normal population (20–30%). MetS prevalence was related to age, GHD duration, and body mass index (BMI), but not to GHD severity, extent of hypopituitarism, or etiology of pituitary disease. Adjusted for age, gender, and BMI, patients with MetS had a higher prevalence ratio for diabetes mellitus: 4.65 (95% confidence interval (CI): 3.29–6.58), for cardiovascular morbidity: 1.91 (95% CI: 1.33–2.75), and for cerebrovascular morbidity: 1.77 (95% CI: 1.09–2.87) than patients without MetS. Conclusions: MetS is highly prevalent in GHD and is associated with a higher prevalence ratio for comorbidities. The presence of MetS in GHD may therefore contribute to the increased risk of cardiovascular morbidity and mortality found in these patients.

Overview

Integrity signals

Registry

Crossref · 10.1530/eje-11-0599

Cites

42 of 42 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 42 references

Cited by

See all 74

Metadata

Authors
Verhelst, J., Mattsson, A. F., Luger, A., Thunander, M., Góth, M. I., Kołtowska-Häggström, M., & Abs, R.
Affiliations
  • ZNA Middelheim Hospital (BE)
  • Pfizer (Sweden) (SE)
  • Medical University of Vienna (AT)
  • Lund University (SE)
Corresponding author
Verhelst, Johan
Venue
European Journal of Endocrinology
Published
2011-12
Volume
165
Issue
6
Pages
881-889
ISSN
  • 0804-4643 (ISSN-L)
  • 1479-683X
OpenAlex
W2159644930
Cited by
71
References
42
Citations by year
2026: 1 · 2025: 3 · 2024: 6 · 2023: 4 · 2022: 5 · 2021: 4 · 2020: 6 · 2019: 5 · 2018: 4 · 2017: 8 · 2016: 3 · 2015: 6 · 2014: 8 · 2013: 1 · 2012: 7
FWCI
4.20
Type
journal article
Language
en
Open access
closed
Locations
  • European Journal of Endocrinology (publishedVersion)
  • PubMed (publishedVersion)
  • Lund University Publications (Lund University) (submittedVersion)
Funders
Pfizer
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Growth Hormone and Insulin-like Growth Factors
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
Keywords
metabolic syndrome, adult-onset growth hormone deficiency, hypopituitarism, growth hormone replacement therapy, prevalence, diabetes mellitus, cardiovascular morbidity, body mass index, comorbidities
MeSH terms
Adult, Age Factors, Female, Humans, Hypopituitarism, Male, Middle Aged, Cohort Studies, Prevalence, Human Growth Hormone, Hormone Replacement Therapy, Metabolic Syndrome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Prevalence and characteristics of the metabolic syndrome in 2479 hypopituitary patients with adult-onset GH deficiency before GH replacement: a KIMS analysis. https://app.cochat.ai/papers/10.1530/eje-11-0599
The paper
Verhelst, J., Mattsson, A. F., Luger, A., Thunander, M., Góth, M. I., Kołtowska-Häggström, M., & Abs, R. (2011). Prevalence and characteristics of the metabolic syndrome in 2479 hypopituitary patients with adult-onset GH deficiency before GH replacement: a KIMS analysis. European Journal of Endocrinology. https://doi.org/10.1530/eje-11-0599

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.